润达医疗1月15日获融资买入1.46亿元，融资余额7.61亿元

Group 1 - The core viewpoint of the news is that RunDa Medical has shown significant trading activity and financial performance indicators, with a notable increase in financing and a decrease in revenue and profit [1][2][3] Group 2 - On January 15, RunDa Medical's stock rose by 1.83%, with a trading volume of 1.391 billion yuan. The financing buy-in amount was 146 million yuan, while the financing repayment was 136 million yuan, resulting in a net financing buy of 10.3757 million yuan [1] - As of January 15, the total balance of margin trading for RunDa Medical was 764 million yuan, with the financing balance accounting for 6.29% of the circulating market value, indicating a high level compared to the past year [1] - The company reported a revenue of 5.268 billion yuan for the period from January to September 2025, representing a year-on-year decrease of 14.70%, and a net profit attributable to shareholders of -163 million yuan, a significant decline of 422.64% [2] - RunDa Medical has distributed a total of 373 million yuan in dividends since its A-share listing, with 165 million yuan distributed over the past three years [3] - As of September 30, 2025, the number of shareholders for RunDa Medical was 64,800, a decrease of 1.05% from the previous period, while the average circulating shares per person increased by 1.06% to 9,317 shares [2][3]